Difference between revisions of "TC99m Biomarker Committee"
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
==Recent Meetings/Call Summaries== | ==Recent Meetings/Call Summaries== | ||
| + | *[[Media:2020_05-12_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | May 12, 2020]] | ||
*[[Media:2020_04-14_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | April 14, 2020]] | *[[Media:2020_04-14_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | April 14, 2020]] | ||
*[[Media:2020_03-10_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | March 10, 2020]] | *[[Media:2020_03-10_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | March 10, 2020]] | ||
Revision as of 20:40, 11 June 2020
- Co-chairs: Yuni Dewaraja, PhD; Robert Miyaoka, PhD
- RSNA Staff Support: Julie Lisiecki
Full name of biomarker committee: Technetium-99m for body, oncology, and immunology
Recent Meetings/Call Summaries
Break during Profile Public Comment period
- October 8, 2019
- September 10, 2019
- August 13, 2019
- July 9, 2019
- May 14, 2019
- April 9, 2019
- March 12, 2019
SPECT TC99m BC Call Summaries Archive